We are live on ! Find out more
PBLA

Panbela Therapeutics, Inc. Common Stock
PBLA

Delisted

PBLA was delisted on the 6th of March, 2024.

Back to rankings

11 hedge funds and large institutions have $3.12M invested in Panbela Therapeutics, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 1

57% more funds holding

Funds holding: 7 → 11 (+4)

14% more capital invested

Capital invested by funds: $2.74M → $3.12M (+$383K)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

Holders
11
Holders Change
+4
Holders Change %
+57.14%
% of All Funds
0.19%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
1
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$780K
2
CH
CVI Holdings
Delaware
+$195K
3
NAM
NewGen Asset Management
Ontario, Canada
+$195K
4
BlackRock
BlackRock
New York
+$97.5K
5
BSW
Buckingham Strategic Wealth
Missouri
+$97.5K

Top Sellers

Rank Fund Capital Flow
1
FPS
Fieldpoint Private Securities
Connecticut
-$195K
2
Squarepoint
Squarepoint
New York
-$61K
3
VFA
Valeo Financial Advisors
Indiana
-$10K
4
TRCT
Tower Research Capital (TRC)
New York
-$3K
5
Osaic Holdings
Osaic Holdings
Arizona
-$1K
Name Holding Trade Value Shares
Change 		Change in
Stake
IC
1
Ikarian Capital
Texas
$976K – – –
Vanguard Group
2
Vanguard Group
Pennsylvania
$615K +$780K +8 +800%
M
3
Murchinson
Ontario, Canada
$425K +$585K +6 New
FPS
4
Fieldpoint Private Securities
Connecticut
$359K -$195K -2 -25%
BAMG
5
Brand Asset Management Group
Missouri
$162K – – –
CH
6
CVI Holdings
Delaware
$118K +$195K +2 New
BFM
7
Boothbay Fund Management
New York
$115K – – –
NAM
8
NewGen Asset Management
Ontario, Canada
$113K +$195K +2 New
BSW
9
Buckingham Strategic Wealth
Missouri
$71K +$97.5K +1 New
BlackRock
10
BlackRock
New York
$68K +$97.5K +1 New
Verition Fund Management
11
Verition Fund Management
Connecticut
$57K – – –
WAM
12
Warberg Asset Management
Illinois
$33K – – –
Morgan Stanley
13
Morgan Stanley
New York
$7K – – –
Northwestern Mutual Wealth Management
14
Northwestern Mutual Wealth Management
Wisconsin
$2K – – –
PC
15
Permanens Capital
New York
$1K – – –
UBS Group
16
UBS Group
Switzerland
$1K – – –
Squarepoint
17
Squarepoint
New York
– -$61K -1 Closed
Osaic Holdings
18
Osaic Holdings
Arizona
– -$1K – –
TRCT
19
Tower Research Capital (TRC)
New York
– -$3K – –
VFA
20
Valeo Financial Advisors
Indiana
– -$10K – –

PBLA Hedge Fund Activity: Q2 2021 in Review

11 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Panbela Therapeutics, Inc. Common Stock (PBLA) for Q2 2021, worth a combined $3.12M — up 14% from $2.74M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new PBLA positions and 1 closed out — a net gain of 4 holders — while 1 added to existing stakes and 1 trimmed.

The largest buyer was Vanguard Group, adding an estimated $780K. The largest seller was Fieldpoint Private Securities, cutting an estimated $195K.

  • 11 institutional investors held Panbela Therapeutics, Inc. Common Stock (PBLA) as of Q2 2021, up from 7 in Q1 2021.
  • Funds reported $3.12M of Panbela Therapeutics, Inc. Common Stock stock for Q2 2021, up 14% quarter-over-quarter.
  • 5 funds opened new Panbela Therapeutics, Inc. Common Stock positions in Q2 2021 and 1 closed out, a net change of +4 holders.
  • The largest Panbela Therapeutics, Inc. Common Stock buyer in Q2 2021 was Vanguard Group, an estimated $780K added.
  • The largest Panbela Therapeutics, Inc. Common Stock seller in Q2 2021 was Fieldpoint Private Securities, an estimated $195K sold.

Based on aggregated 13F filings for Q2 2021.